Viewing StudyNCT06444087



Ignite Creation Date: 2024-06-16 @ 11:51 AM
Last Modification Date: 2024-10-26 @ 3:31 PM
Study NCT ID: NCT06444087
Status: RECRUITING
Last Update Posted: 2024-06-24
First Post: 2024-05-30

Brief Title: Patients Perspective on the Evolution of Hidradenitis Suppurativa Burden After Secukinumab Initiation
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Hidradenitis Suppurativa
Keywords:
Name View
France View
secukinumab View
Hidradenitis Suppurativa View
HS View
NIS View